Spravato Dosage: Form, Strength, How to Take, and More

Spravato’s dosing is a little like a theme-park ride: there’s a set schedule, a safety checklist, and a trained staff member
who definitely does not let you wander off mid-loop-de-loop. That’s because Spravato (esketamine) is a prescription nasal spray
used for certain forms of serious depression in adultsand it comes with required in-clinic monitoring, not “take two and call me in the morning.”

In this guide, we’ll break down Spravato’s form, strength, dose schedules, and the
step-by-step “how it’s taken” processplus what real-world treatment days often feel like. (Spoiler: many people say the
waiting room playlist matters more than they expected.)

What Spravato Is (and Why the Dosage Works Differently)

Spravato is the brand name for esketamine, a ketamine-derived medicine that affects brain signaling differently than
traditional daily antidepressant pills. In the U.S., it’s indicated for:

• Treatment-resistant depression (TRD) in adultsas monotherapy or with an oral antidepressant.
• Depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behaviorin conjunction with an oral antidepressant.

A key limitation is worth saying out loud: Spravato has not been shown to prevent suicide or to reduce suicidal thoughts/behaviors as an outcome,
and clinical teams still make decisions about higher levels of care (including hospitalization) based on the full picture.

Also important: Spravato is not approved for people under 18. If you’re a teen and seeing this topic online,
the safest takeaway is: this is adult-only territory, and treatment decisions should happen with qualified clinicians.

Spravato Form and Strength

Spravato is a nasal spray that comes in a single-use device.
Each device delivers two sprays total (one spray per nostril) and contains:

• 28 mg of esketamine per device (total dose from that device)

Because the device is fixed at 28 mg, the common session doses are built by using multiple devices:

• 56 mg dose = 2 devices (2 × 28 mg)
• 84 mg dose = 3 devices (3 × 28 mg)

This “device math” is why you’ll hear clinics talk in both mg and devices. It’s not them being fancyit’s just how the product is packaged.

Spravato Dosage for Treatment-Resistant Depression (TRD)

For TRD in adults, Spravato is typically started with a more frequent schedule (to build response) and then spaced out
(to maintain response using the least frequent schedule that still works).

The “best” dose (56 vs 84) is not a personality test. It’s a clinician-and-patient decision based on
benefit and tolerability. Many people start at one dose and adjust if side effects are too rough
or if symptom improvement isn’t where the team wants it.

Why the frequency changes over time

Think of induction like jump-starting a car battery: you need more frequent sessions early on to build momentum.
Maintenance is the “keep it running” phaseoften with fewer sessions as stability improves. Clinicians aim for the
least frequent dosing that still maintains response, because time is valuable and so are your Tuesdays.

Spravato Dosage for MDD With Acute Suicidal Ideation or Behavior

For depressive symptoms in adults with MDD with acute suicidal ideation or behavior, the recommended regimen is:

• 84 mg twice weekly for 4 weeks
• May be reduced to 56 mg twice weekly based on tolerability

After the initial 4 weeks, clinicians evaluate whether ongoing treatment is needed. The evidence for continuing Spravato
beyond 4 weeks in this specific acute setting has not been systematically established, so teams reassess carefully and
tailor next steps to the person’s overall treatment plan and safety needs.

How to Take Spravato (What Happens at a Treatment Session)

Spravato isn’t a “pick it up at the pharmacy and use it at home” medication. It’s only available through a
restricted safety program (REMS), and it must be administered under direct supervision in a certified healthcare setting.
Translation: you’re not doing this between algebra homework and dinner.

Before you arrive: prep that actually matters

• Don’t eat for at least 2 hours before the session (helps reduce nausea/vomiting).
• Don’t drink liquids for at least 30 minutes before the session.
• If you use a nasal steroid or nasal decongestant on dosing days, take it at least 1 hour before Spravato.
• Plan a ride home. You should not drive until the next day after a restful sleep.

Step-by-step: the actual nasal spray process

During the session, a healthcare professional supervises while the patient self-administers the spray using one device at a time.
Typical instructions include:

1. Blow your nose before the first device (so the medicine can actually reach nasal tissue).
2. Sit in a comfortable, semi-reclined position.
3. Use the device to spray one spray per nostril (that completes that device’s 28 mg dose).
4. Rest for 5 minutes after each device before using the next one (absorption time matters).
5. If liquid drips out, dab with a tissuedon’t blow your nose right after.

The total session dose depends on the prescription: 2 devices for 56 mg or 3 devices for 84 mg, with those 5-minute rests between devices.

After dosing: why you’re monitored (and for how long)

After administration, patients are monitored for at least 2 hours. Clinics commonly check:

• Sedation (sleepiness, slowed response)
• Dissociation (feeling detached or “spacey”)
• Breathing status (including pulse oximetry, per guidance)
• Blood pressure (often rechecked around ~40 minutes post-dose and again as needed)

If blood pressure is coming down and the person is clinically stable, discharge may happen after the monitoring window.
If not, monitoring continues until it’s safe.

Spravato Dose Adjustments: When 56 mg vs 84 mg Makes Sense

In real practice, Spravato dosing isn’t about “toughing it out.” It’s about finding a balance between
symptom improvement and side effects. A clinician may adjust dose or frequency for reasons like:

• Tolerability: If side effects (like nausea, dizziness, intense dissociation, or sedation) are too disruptive, reducing from 84 mg to 56 mg may be considered.
• Efficacy: If response is partial, clinicians may consider a different dose option or adjust frequency within approved schedules.
• Blood pressure changes: Because Spravato can raise blood pressure, clinics take baseline readings seriously and monitor closely.

What If You Miss a Session?

Missed sessions happenlife loves to throw surprise meetings, sick kids, and traffic at your calendar.
Generally, if there’s no worsening in depressive symptoms, patients may continue the current schedule.
If symptoms worsen during maintenance, clinicians may consider returning to a more frequent schedule (for example, moving back from weekly to twice weekly),
based on clinical judgment.

Drug Interactions and Substances That Can Affect Monitoring

Spravato is monitored in part because it can cause sedation and affect perception. Certain substances and medications can increase risks:

• CNS depressants (for example, benzodiazepines, opioids, alcohol) may increase sedationclinicians may monitor more closely.
• Psychostimulants (for example, amphetamines, methylphenidate, modafinil/armodafinil) may increase blood pressureBP monitoring is especially important.
• MAOIs may also increase blood pressureagain, closer BP monitoring may be needed.

Always bring an up-to-date medication list to each visitincluding supplements and “I only take it sometimes” meds. The clinic can only manage what it knows about.

Side Effects: What People Commonly Notice on Dosing Days

Not everyone experiences the same effects, but common side effects reported during and after sessions include:

• Dissociation (feeling detached, time distortion)
• Dizziness or a spinning sensation
• Nausea (sometimes vomitinghence the “no eating” rule)
• Sedation or feeling very sleepy
• Numbness or unusual sensations

Clinics watch for more serious risks too, including significant blood pressure increases and breathing-related concerns.
This is exactly why the REMS program and monitoring requirements exist: safety isn’t an afterthought hereit’s built into the treatment model.

FAQ: Quick Answers That Save You a Scroll

How long does a Spravato appointment take?

Plan for the dosing process plus at least 2 hours of observation, and add extra time for check-in and discharge.
Many clinics recommend blocking off a good chunk of the daybecause being “sort of dissociated” is not the ideal state for a surprise conference call.

Can I take Spravato at home?

No. Spravato must be administered under supervision in a certified setting, with required monitoring afterward.

Why can’t I drive afterward?

Because sedation, perception changes, and delayed effects can happen. Patients are instructed not to drive or do hazardous activities
until the next day after a restful sleep.

Does 84 mg work better than 56 mg?

Not automatically. Some people do well at 56 mg, others at 84 mg. Clinicians adjust based on response and tolerability
the goal is the best benefit with acceptable side effects and safe monitoring.

Real-World Experiences: What Treatment Days Often Feel Like (About 500+ Words)

Let’s talk about the part people usually Google at 2:00 a.m.: “Okay, but what does a Spravato session actually feel like?”
Experiences vary widely, but patterns show up across many patient stories and clinic routines.

First, the logistics are real. Many patients say the most challenging part isn’t the sprayit’s planning the day. You’re arranging a ride,
skipping food for a couple hours, and showing up knowing you’ll be monitored afterward. Some people treat it like a standing appointment with themselves:
comfy clothes, phone on Do Not Disturb, and a playlist downloaded in advance (because Wi-Fi in medical buildings can be… aspirational).

The intake process often feels reassuringly structured. Blood pressure checks, a quick “how are you doing today?” conversation,
and sometimes paperwork if the clinic needs to document safety steps. People who get anxious about medical settings often say the predictability helps:
the session has a script, the staff know what to watch for, and there’s a clear finish line.

During dosing, the most common “surprise” is how quick the sensation shift can be. Some describe a floaty, dreamy, or “buzzing” feeling within minutes.
Others feel mostly normal at first and then notice changes closer to the midpoint of the session. Dissociation is frequently described as a sense of distance
like watching your thoughts from the other side of a window, or feeling time stretch and compress in strange ways. Importantly, many people say it’s not
scary once they know it’s expected and temporary. Having a calm environment matters: dim lighting, a recliner, a blanket, and minimal interruptions can make
the experience feel less like “medical procedure” and more like “guided reset.”

Side effects get their own reviews. Nausea is a common complaint (again, hello fasting rules), and some clinics offer simple supports like anti-nausea options
when appropriate, water later in the session, or peppermint/ginger strategies depending on clinic policy. Dizziness or a “wobbly” feeling is also common,
which is why staff often encourage staying seated and not popping up like you’re late for a bus.

The two-hour monitoring window can feel longor strangely shortdepending on the person. Some patients use the time to rest with eyes closed and music.
Others journal. Some do breathing exercises. Many report a “come-down” phase where the intense sensations fade and a tired, quiet mood settles in.
People often say they’re glad they didn’t plan anything demanding afterward. Even if you feel “fine,” the day can have a post-session fog, like waking from a deep nap.

When it comes to outcomes, patient experiences can range from “I noticed a lift quickly” to “it was subtle, gradual, and I had to look back over weeks to see it.”
Many describe benefits as improved ability to function, less heaviness, or more mental flexibilitynot constant happiness. That difference matters.
Depression treatment isn’t usually a fireworks show; for many, it’s a slow return of color in a world that had gone gray.

Finally, a consistent theme: people do best when Spravato is treated as part of a bigger plan. Therapy, sleep habits, support systems,
and ongoing medication decisions all play roles. Patients often describe Spravato as opening a doorwhile the rest of treatment helps them walk through it.

Conclusion

Spravato dosing is designed around two truths: depression can be severe and urgent, and treatment has to be delivered safely.
With fixed 28 mg nasal spray devices (combined into 56 mg or 84 mg doses), structured induction/maintenance schedules, and required in-clinic monitoring,
Spravato is one of the most “supervised” depression treatments in routine outpatient care. If you’re considering it (or supporting someone who is),
the best next step is a detailed conversation with a qualified clinician about candidacy, safety, expectations, and how dosing will be tailored over time.